InfoHub Logo

Kazakhstan's Ministry of Health, through its Committee for Medical and Pharmaceutical Control, has issued an order to withdraw a specific batch of the medication 'Streptocide' from circulation and prohibit its medical use. This directive, detailed in an order by the committee chairman dated February 23, 2026, impacts a particular production lot of this common antibacterial drug.

Affected Medication Details

The restriction specifically targets batch number RK-LS-5 № 003366 of 'Streptocide, tablets, 300 milligrams, in contour cell packaging of 10 tablets. Five contour cell packages in a cardboard box'. This medication is manufactured by the Kazakh company 'KhimPharm' JSC. The affected batch had an expiration date of August 2030.

Understanding Streptocide

'Streptocide' is a synthetic antibacterial agent belonging to the sulfonamide group. It functions by inhibiting the growth and reproduction of bacteria, exhibiting a bacteriostatic effect. This medication is commonly prescribed for various bacterial infections, including those affecting the skin, wounds, burns, mucous membranes, and respiratory tract.

Reason for Recall Unspecified

While the order mandates the removal of this specific batch from pharmacies, medical facilities, and other points of sale, the precise reasons behind the recall have not been publicly disclosed in the order. The task of implementing this ban has been assigned to the department for conducting unscheduled inspections of pharmaceutical activities.

Broader Context of Drug Recalls

This action follows previous instances of medication recalls in Kazakhstan. Notably, the drug 'Isoptin' (active substance – verapamil) 40 mg, manufactured in Germany, was previously banned from official sale and distribution. Additionally, a generic version of 'Viagra' was also withdrawn from the market within the country.

This information was reported by Infohub.kz.